BioSpace News Archive

Biofrontera Inc. announced today financial results for the three and six months ended June 30, 2022 and provided a business update.

AmerisourceBergen Hosts Inaugural Disparities in Cancer Care Summit.

Royal Philips (NYSE: PHG, AEX: PHIA), today announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease (PVD): the establishment of the first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in lower extremity arterial and venous interventions.

Lunit, a global provider of AI-powered cancer solutions, announced strong financial results for the second quarter of the fiscal year 2022.

Humana Inc. (NYSE: HUM) announced today that it will acquire substantially all of the assets of Inclusa, Inc., a Managed Care Organization (“MCO”) in Wisconsin that provides long-term care services and supports to approximately 16,600 older adults and adults with disabilities through the state’s Family Care program.

Therapeutic Solutions International announced today new data demonstrating superior effects of the Company’s ApoptoCyte™ procedure treated JadiCell™ product compared to other stem cells in treating an animal model of Chronic Obstructive Pulmonary Disease (COPD).

StageZero Life Sciences announced that it will release its second quarter operational and financial results before the markets open on Tuesday, August 16, 2022.

Progressive Care, Inc., a personalized healthcare services and technology provider, announced financial and operational results for the three and six months ended June 30, 2022.

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) announces that it has closed a second tranche of its previously announced non-brokered private placement of units (“Units”) as announced on May 19, 2022 for gross proceeds of $1,364,710.10 (the “Offering”).

A study led by Kaiser Permanente in Southern California of patients from 8 health care organizations across the United States showed that COVID-19 was associated with a 4% increase in use of health care services over the 6 months after initial infection.